Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 October 2006

Malignant solitary fibrous tumor originating from the peritoneum and reviewof the literature.

Moritsugu Tanaka, Hirozumi Sawai, Yuji Okada, Minoru Yamamoto, Hitoshi Funahashi, Tetsushi Hayakawa, Hiromitsu Takeyama, Tadao Manabe

Med Sci Monit 2006; 12(10): CS95-98 :: ID: 459077


Background: Solitary fibrous tumor (SFT) is a rare neoplasm frequentlyinvolving the pleura. Benign and malignant forms of the tumor occur, the benign variant being three tofour times more common than the malignant. Case Report: We present herein a rare case of large malignantsolitary fibrous tumor (SFT) originating from the peritoneum. An abdominal computed tomography scan revealeda well-defined solid tumor with mixed density. An abdominal ultrasonography (US) revealed a well-circumscribedsolid tumor containing a partially cystic lesion. T1-weighted abdominal magnetic resonance imaging demonstrateda hypo- to isointensity, which was a hypo- to hyperintensity on T2-weighted images. Liposarcoma originatingfrom the retroperitoneum was suggested, and the patient underwent a complete resection of the tumor aswell as the left kidney because tumor invasion of the upper left kidney was suspected. Immunohistochemically,the spindle-shaped cells were positive for CD34, and the diagnosis was SFT originating from the peritoneum.At the 14-month follow-up evaluation, no recurrence or metastasis was detected. Conclusions: This casegave us some difficulty, and the correct diagnosis of the peritoneal mass was valuable. To diagnose themalignant potential of this type of tumor accurately may have value to direct the appropriate therapeuticoperations after surgery and postoperative progress observation.

Keywords: Antigens, CD34 - metabolism, Follow-Up Studies, Neoplasms, Fibrous Tissue - surgery, Peritoneal Neoplasms - surgery, Time Factors, Tomography, X-Ray Computed

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Database Analysis  

Long-Term Prognosis of Patients Undergoing Percutaneous Coronary Intervention: The Impact of Serum Creatini...

Med Sci Monit In Press; DOI: 10.12659/MSM.943063  

Database Analysis  

Maternal Exposure to Environmental Air Pollution and Premature Rupture of Membranes: Evidence from Southern...

Med Sci Monit In Press; DOI: 10.12659/MSM.943601  

Animal Research  

Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar Rats

Med Sci Monit In Press; DOI: 10.12659/MSM.942485  

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750